Vanguard Group Inc Increases Stake in West Pharmaceutical Services Inc

The Vanguard Group Inc has filed a Schedule 13G/A amendment with the SEC, disclosing an increased stake in West Pharmaceutical Services Inc. As of September 30, 2025, Vanguard holds 9,704,948 shares, representing a 13.49% ownership in the company. This marks an increase of 388,144 shares from their previous filing, with the value of their holdings rising by $698,957,967.36 to a total of $2,737,474,682.36. The filing indicates that Vanguard's clients, including investment companies and managed accounts, have the right to receive dividends and proceeds from the sale of these securities. The amendment was signed by Ashley Grim, Head of Global Fund Administration, on October 31, 2025.